KRRO·Nasdaq·US
Korro Bio
Korro Bio is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines. Its business centers on a proprietary platform, OPERA, and an internal pipeline of therapeutic candidates for rare and prevalent diseases.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.